Pricing Log in Create free account

Absci Corporation (ABSI) vs Structure Therapeutics Inc. Sponsored ADR (GPCR)

Absci Corporation and Structure Therapeutics Inc. Sponsored ADR are both Biotechnology companies. Absci Corporation and Structure Therapeutics Inc. Sponsored ADR are of similar size ($1.6B and $1.5B). Structure Therapeutics Inc. Sponsored ADR has the higher net margin (0.00% vs −7,756.4%) and the lower return on invested capital (−1,371.8% vs −174.7%). Across the 14 metrics below, Structure Therapeutics Inc. Sponsored ADR leads on 8 and Absci Corporation on 6.

Valuation

Metric ABSI GPCR Biotechnology median
P/E n/m n/m 8.50
P/S 832.25 n/m 9.71
P/B 5.28 1.12 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 703.53 n/m 9.21
Earnings yield (9.70%) (14.35%) (33.15%)
Free cash flow yield (8.37%) (14.75%) (25.50%)

Profitability

Metric ABSI GPCR Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (8,084.50%) 0.00% 0.00%
Net margin (7,756.37%) 0.00% 0.00%
Free cash flow margin (6,969.83%) 0.00% 0.00%
Return on equity (57.72%) (20.21%) (56.36%)
Return on assets (50.57%) (19.17%) (48.04%)
Return on invested capital (174.74%) (1,371.78%) 0.00%

Growth

Metric ABSI GPCR Biotechnology median
Revenue growth (TTM) (62.28%) — 6.02%
EPS growth (last fiscal year) 10.64% (2.47%) 30.26%
Revenue growth, 5-year CAGR (10.14%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABSI GPCR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.63 20.75 4.72
Net debt to EBITDA 1.32 8.27 0.96

Dividend

Metric ABSI GPCR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABSI GPCR Biotechnology median
Market cap 1.52b 1.58b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack